This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Ramachandran, H. Articles by Kurup, V. P. Search for Related Content PubMed PubMed Citation Articles by Ramachandran, H. Articles by Kurup, V. P.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, March 2004, p. 261-265, Vol. 11, No. 2
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.2.261-265.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Role of C-Terminal Cysteine Residues of Aspergillus fumigatus Allergen Asp f 4 in Immunoglobulin E Binding

Department of Pediatrics, Allergy-Immunology Division, Medical College of Wisconsin, Milwaukee, Wisconsin 53226,¹ Research Service, Veterans Affairs Medical Center, Milwaukee, Wisconsin 53295,³ Division of Allergy-Immunology, Northwestern University Medical School, Chicago, Illinois 60611²

Received 15 August 2003/ Returned for modification 7 October 2003/ Accepted 8 December 2003

Among the several allergens cloned and expressed from Aspergillus fumigatus, Asp f 4 is a major one associated with allergic bronchopulmonary aspergillosis (ABPA). The structure-function relationship of allergens is important in understanding the immunopathogenesis, diagnosis, and treatment of allergic diseases. These include the epitopes, conformational or linear, deletion of the N or C terminus or both N and C termini, and glycosylation or nonglycosylation, all of which affect immune responses. Similarly, the role of cysteine residues present in allergens may yield useful information regarding the conformational structure of allergens and the immunoglobulin E (IgE) epitope interaction. Such information may help in developing new strategies towards immunotherapy. In order to define the role of cysteine in the interaction of the antibody with Asp f 4, we have constructed mutants by selectively deleting cysteine residues from the C-terminal region of the Asp f 4. Immunological evaluation of these engineered recombinant constructs was conducted by using sera from patients with ABPA, Aspergillus skin test-positive asthmatics, and healthy controls. The results demonstrate strong IgE binding with Asp f 4 and two truncated mutants, Asp f 4_1-234 (amino acids [aa] 1 to 234) and Asp f 4_1-241 (aa 1 to 241), while another mutant, Asp f 4_1-196 (aa 1 to 196), showed reactivity with fewer patients. The result suggests that deletion of cysteines and the alteration of IgE epitopes at the C-terminal end resulted in conformational changes, which may have a potential role in the immunomodulation of the disease.